Cheng Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cheng Zhang has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- Tai Ma
Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China
5 shared publications - Chong Feng
Department of Noncommunicable Diseases and Health Education Hefei Center for Disease Control and Prevention Hefei People's Republic of China
3 shared publications - Hui Xu
Department of Oncology The First Affiliated Hospital of Anhui Medical University Hefei People's Republic of China
3 shared publications - Minmin Xie
Department of Oncology The First Affiliated Hospital of Anhui Medical University Hefei People's Republic of China
3 shared publications - Xiaopeng Zhang
Department of Noncommunicable Diseases and Health Education Hefei Center for Disease Control and Prevention Hefei People's Republic of China
3 shared publications - Yahui Yang
Department of Oncology The First Affiliated Hospital of Anhui Medical University Hefei People's Republic of China
3 shared publications
Latest Publications
- Open Access
- 2 December 2025
- Published by Springer Nature in Research Square
The influence of dynamic trajectories of red blood cell distribution width on prognosis and causal mediation analysis in sepsis patients: a longitudinal study with external validation
Background: Sepsis is a highly heterogeneous syndrome, and static clinical data do not provide a comprehensive characterization of the full spectrum of patient conditions. This study investigated sepsis subtypes based on the dynamic trajectory of red cell distribution width (RDW) aiming at better risk stratification of patients. Methods: This retrospective study included a derived cohort of sepsis patients from the Medical Informatics Marketplace Intensive Care Database (MIMIC IV) and an external validation cohort of sepsis patients from the First Affiliated Hospital of AnHui Medical University department of Critical Care medicine Data Mart (AHCCDM) between January 2019 and June 2025. Latent Class Trajectory Modeling (LCTM) was employed to identify distinct RDW trajectories over the first 5 days following ICU admission. We compared the clinical characteristics and outcomes of patients in these subphenotypes to evaluate the prognostic significance of RDW trajectory patterns in sepsis. Causal moderation analyses were applied to determine whether changes in RDW trajectories mediated survival outcomes in patients with sepsis through other variables. Results: A total of 20,485 sepsis patients from the MIMIC-IV database were included in the study as the derived cohort, and 627 sepsis patients from the AHCCDM dataset served as the external validation cohort. Based on the RDW trajectory analysis, three different subtypes were identified, Class 1: stable, normal RDW; Class 2: rapidly increasing and severely abnormal RDW; Class 3: stable, elevated RDW. Among them, the clinical characteristics of patients in category 2 included higher severity, more severe inflammatory response, and more severe organ damage. Using Kaplan-Meier survival curve analysis to compare the incidence of the primary outcome between groups, patients with class 2 sepsis had a significantly higher risk of death at 30, 60, and 90 days than class 3 and 1. External validation revealed that the RDW trajectories were also classified into three distinct groups, with patients in all three groups exhibiting similar mortality trends.Mediated causality analyses indicated that the dynamic trajectory of RDW mediated the risk of death in sepsis patients through an increase in RDW. Conclusion: Dynamic RDW trajectories identify distinct sepsis subphenotypes associated with disease severity and mortality. Serial RDW monitoring may serve as a simple tool for early risk stratification and individualized sepsis management.
- 2 December 2025
- Published by Springer Nature in Research Square
Open AccessThe influence of dynamic trajectories of red blood cell distribution width on prognosis and causal mediation analysis in sepsis patients: a longitudinal study with external validation
Background: Sepsis is a highly heterogeneous syndrome, and static clinical data do not provide a comprehensive characterization of the full spectrum of patient conditions. This study investigated sepsis subtypes based on the dynamic trajectory of red cell distribution width (RDW) aiming at better risk stratification of patients. Methods: This retrospective study included a derived cohort of sepsis patients from the Medical Informatics Marketplace Intensive Care Database (MIMIC IV) and an external validation cohort of sepsis patients from the First Affiliated Hospital of AnHui Medical University department of Critical Care medicine Data Mart (AHCCDM) between January 2019 and June 2025. Latent Class Trajectory Modeling (LCTM) was employed to identify distinct RDW trajectories over the first 5 days following ICU admission. We compared the clinical characteristics and outcomes of patients in these subphenotypes to evaluate the prognostic significance of RDW trajectory patterns in sepsis. Causal moderation analyses were applied to determine whether changes in RDW trajectories mediated survival outcomes in patients with sepsis through other variables. Results: A total of 20,485 sepsis patients from the MIMIC-IV database were included in the study as the derived cohort, and 627 sepsis patients from the AHCCDM dataset served as the external validation cohort. Based on the RDW trajectory analysis, three different subtypes were identified, Class 1: stable, normal RDW; Class 2: rapidly increasing and severely abnormal RDW; Class 3: stable, elevated RDW. Among them, the clinical characteristics of patients in category 2 included higher severity, more severe inflammatory response, and more severe organ damage. Using Kaplan-Meier survival curve analysis to compare the incidence of the primary outcome between groups, patients with class 2 sepsis had a significantly higher risk of death at 30, 60, and 90 days than class 3 and 1. External validation revealed that the RDW trajectories were also classified into three distinct groups, with patients in all three groups exhibiting similar mortality trends.Mediated causality analyses indicated that the dynamic trajectory of RDW mediated the risk of death in sepsis patients through an increase in RDW. Conclusion: Dynamic RDW trajectories identify distinct sepsis subphenotypes associated with disease severity and mortality. Serial RDW monitoring may serve as a simple tool for early risk stratification and individualized sepsis management.
- 1 October 2025
- Published by American Society of Clinical Oncology (ASCO) in JCO Precision Oncology
- Vol. 9 (9) , e2500664
Timing of Adjuvant Chemotherapy After Gastrectomy in Patients With Stage II to III Gastric Cancer: A Target Trial Emulation Study
PURPOSE: Uncertainty persists regarding the optimal interval between D2 gastrectomy and initiation of adjuvant chemotherapy (AC) for stage II to III gastric cancer (GC). We investigated whether delaying treatment beyond 6 weeks compromises overall survival. MATERIALS AND METHODS: Using multicenter observational data (2010-2022), we emulated a pragmatic noninferiority target trial to compare AC initiation at ≤6 versus 7-12 weeks postgastrectomy. Eligible patients had received curative-intent surgery for stage II to III GC. The AC regimen comprised platinum-based agents plus fluoropyrimidines. The primary end point was 5-year all-cause mortality from surgery to death or administrative censoring (30 June 2025). The Clone-censor-weighting approach was used, and inverse probability weighting achieved balance across baseline and postoperative time-varying covariates (standardized mean difference <0.1). Weighted pooled logistic regression estimated cumulative mortality; risk differences (RDs) and risk ratios (RRs) were computed from 500 bootstrap samples. The prespecified noninferiority margin was an absolute 10% increase in 5-year mortality. RESULT: Among 1,637 eligible patients, 35.9% initiated AC within 6 weeks (median 37 days), whereas 17.5% began between 7 and 12 weeks postoperatively. Delayed initiation (7-12 weeks) met the noninferiority criterion: the absolute RD in 5-year mortality was –0.52% (95% CI, –7.95 to 7.41), with the upper confidence limit below the 10% margin. The noninferiority finding was robust to weight trimming and to alternative imputation strategies. No significant difference in mortality was observed across clinically relevant subgroups. CONCLUSION: Initiating AC 7-12 weeks after D2 gastrectomy appeared to be noninferior to initiation within 6 weeks with respect to 5-year mortality in stage II to III GC; however, residual confounding cannot be excluded and the findings require validation in further studies.
- 1 October 2025
- Published by American Society of Clinical Oncology (ASCO) in JCO Precision Oncology
- Vol. 9 (9) , e2500664
Timing of Adjuvant Chemotherapy After Gastrectomy in Patients With Stage II to III Gastric Cancer: A Target Trial Emulation Study
PURPOSE: Uncertainty persists regarding the optimal interval between D2 gastrectomy and initiation of adjuvant chemotherapy (AC) for stage II to III gastric cancer (GC). We investigated whether delaying treatment beyond 6 weeks compromises overall survival. MATERIALS AND METHODS: Using multicenter observational data (2010-2022), we emulated a pragmatic noninferiority target trial to compare AC initiation at ≤6 versus 7-12 weeks postgastrectomy. Eligible patients had received curative-intent surgery for stage II to III GC. The AC regimen comprised platinum-based agents plus fluoropyrimidines. The primary end point was 5-year all-cause mortality from surgery to death or administrative censoring (30 June 2025). The Clone-censor-weighting approach was used, and inverse probability weighting achieved balance across baseline and postoperative time-varying covariates (standardized mean difference <0.1). Weighted pooled logistic regression estimated cumulative mortality; risk differences (RDs) and risk ratios (RRs) were computed from 500 bootstrap samples. The prespecified noninferiority margin was an absolute 10% increase in 5-year mortality. RESULT: Among 1,637 eligible patients, 35.9% initiated AC within 6 weeks (median 37 days), whereas 17.5% began between 7 and 12 weeks postoperatively. Delayed initiation (7-12 weeks) met the noninferiority criterion: the absolute RD in 5-year mortality was –0.52% (95% CI, –7.95 to 7.41), with the upper confidence limit below the 10% margin. The noninferiority finding was robust to weight trimming and to alternative imputation strategies. No significant difference in mortality was observed across clinically relevant subgroups. CONCLUSION: Initiating AC 7-12 weeks after D2 gastrectomy appeared to be noninferior to initiation within 6 weeks with respect to 5-year mortality in stage II to III GC; however, residual confounding cannot be excluded and the findings require validation in further studies.
- Open Access
- 27 December 2024
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 12 (1) , 203-212
Real‐world efficacy of transfusion with liberal or restrictive strategy in traumatic brain injury
Objective: The short‐term efficacy of red blood cell (RBC) transfusion among general traumatic brain injury (TBI) patients is unclear.Methods: We used the MIMIC database to compare the efficacy of liberal (10 g/dL) versus conservative (7 g/dL) transfusion strategy in TBI patients. The outcomes were neurological progression (decrease of Glasgow coma scale (GCS) of at least 2 points) and death within 28 days of ICU admission. Each eligible individual was cloned and assigned each of the replicates to one of the treatment arm. The imbalance induced by informative censoring was adjusted by inverse probability weighting. The standardized, weighted pooled logistic regression with 500 bootstrap resampling was used to estimate the cumulative risk difference and 95% confidence interval (CI).Results: Of the 1141 eligible individuals, 29.0% received RBC transfusion. Compared with the restrictive group, the liberal strategy reduced early death (3 days: 5%, 95% CI: 2%–7%; 7 days: 6%, 95% CI: 3%–11%); however, no significant difference of mortality risk at 28‐day or neurological progression risk at any time points was observed. The risk of coagulopathy at 3 days was increased by 7% (95% CI: 1%–19%) in the liberal group. The subgroup analysis indicated a beneficial effect of liberal transfusion on mortality in hemodynamically unstable patients.Interpretation: Compared with the restrictive strategy, the liberal strategy does not improve the short‐term neurological prognosis and death among patients with TBI in a real‐world situation. The liberal strategy may be beneficial to survival at very early stage or in hemodynamically unstable subgroup.
- 27 December 2024
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 12 (1) , 203-212
Open AccessReal‐world efficacy of transfusion with liberal or restrictive strategy in traumatic brain injury
Objective: The short‐term efficacy of red blood cell (RBC) transfusion among general traumatic brain injury (TBI) patients is unclear.Methods: We used the MIMIC database to compare the efficacy of liberal (10 g/dL) versus conservative (7 g/dL) transfusion strategy in TBI patients. The outcomes were neurological progression (decrease of Glasgow coma scale (GCS) of at least 2 points) and death within 28 days of ICU admission. Each eligible individual was cloned and assigned each of the replicates to one of the treatment arm. The imbalance induced by informative censoring was adjusted by inverse probability weighting. The standardized, weighted pooled logistic regression with 500 bootstrap resampling was used to estimate the cumulative risk difference and 95% confidence interval (CI).Results: Of the 1141 eligible individuals, 29.0% received RBC transfusion. Compared with the restrictive group, the liberal strategy reduced early death (3 days: 5%, 95% CI: 2%–7%; 7 days: 6%, 95% CI: 3%–11%); however, no significant difference of mortality risk at 28‐day or neurological progression risk at any time points was observed. The risk of coagulopathy at 3 days was increased by 7% (95% CI: 1%–19%) in the liberal group. The subgroup analysis indicated a beneficial effect of liberal transfusion on mortality in hemodynamically unstable patients.Interpretation: Compared with the restrictive strategy, the liberal strategy does not improve the short‐term neurological prognosis and death among patients with TBI in a real‐world situation. The liberal strategy may be beneficial to survival at very early stage or in hemodynamically unstable subgroup.
- Open Access
- 7 February 2024
- Published by Elsevier in Eco-Environment & Health
- Vol. 3 (4) , 425-435
Associating prenatal phthalate exposure with childhood autistic traits: Investigating potential adverse outcome pathways and the modifying effects of maternal vitamin D
- 7 February 2024
- Published by Elsevier in Eco-Environment & Health
- Vol. 3 (4) , 425-435
Open AccessAssociating prenatal phthalate exposure with childhood autistic traits: Investigating potential adverse outcome pathways and the modifying effects of maternal vitamin D
- Open Access
- 4 September 2022
- Published by Wiley in Cancer Medicine
- Vol. 12 (3) , 2831-2841
Incorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy
Background: Gastric cancer liver metastasis (GCLM) patients usually accompany by abnormal serum liver function tests (LFTs) more or less; however, the prognostic value of LFTs is not fully understood. This study aimed to develop a liver chemistry score (LCS) based on LFTs and incorporate it into prognosis determination for GCLM patients who received palliative chemotherapy.Methods: Data were derived from hospitalized GCLM patients in two general hospitals in China. LCS was generated based on the results of LFTs by LASSO regression. Cutoff value of the score was determined by restricted cubic spline. The score was then incorporated into Cox regression analysis to construct a predictive nomogram; the model was then evaluated internally and externally by AUC of time‐dependent receiver operating characteristic curves (ROC) and calibration curves.Results: Three hundred and thirty‐six and 72 patients were included in development and validation cohort, respectively. LASSO regression analysis in development cohort finally reached a two‐parametric LCS calculated on AST and ALP levels as 0.03343515 × ln (AST, U/L) + 0.02687997 × ln (ALP, U/L), and 0.232 was set as optimal cutoff value. Patients in low (LCS < 0.232) or high (LCS ≥ 0.232) score group experienced different survival times; median OS was 13.54 (95% CI: 11.1–15.6) months in the low LCS group and 7.3 (6.6–9.3) months in the high LCS group (p < 0.001). A nomogram including LCS and other clinical parameters was constructed and showed superior performance than model not including LCS. AUC of 6‐month ROC improved from 0.647 (95% CI: 0.584–0.711) to 0.699 (0.638–0.759) in internal validation, and 0.837 (0.734–0.940) to 0.875 (0.784–0.966) in external validation.Conclusions: Liver chemistry score is useful in determining the prognosis of gastric cancer patients with liver metastasis and may be helpful to clinicians in decision‐making.
- 4 September 2022
- Published by Wiley in Cancer Medicine
- Vol. 12 (3) , 2831-2841
Open AccessIncorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy
Background: Gastric cancer liver metastasis (GCLM) patients usually accompany by abnormal serum liver function tests (LFTs) more or less; however, the prognostic value of LFTs is not fully understood. This study aimed to develop a liver chemistry score (LCS) based on LFTs and incorporate it into prognosis determination for GCLM patients who received palliative chemotherapy.Methods: Data were derived from hospitalized GCLM patients in two general hospitals in China. LCS was generated based on the results of LFTs by LASSO regression. Cutoff value of the score was determined by restricted cubic spline. The score was then incorporated into Cox regression analysis to construct a predictive nomogram; the model was then evaluated internally and externally by AUC of time‐dependent receiver operating characteristic curves (ROC) and calibration curves.Results: Three hundred and thirty‐six and 72 patients were included in development and validation cohort, respectively. LASSO regression analysis in development cohort finally reached a two‐parametric LCS calculated on AST and ALP levels as 0.03343515 × ln (AST, U/L) + 0.02687997 × ln (ALP, U/L), and 0.232 was set as optimal cutoff value. Patients in low (LCS < 0.232) or high (LCS ≥ 0.232) score group experienced different survival times; median OS was 13.54 (95% CI: 11.1–15.6) months in the low LCS group and 7.3 (6.6–9.3) months in the high LCS group (p < 0.001). A nomogram including LCS and other clinical parameters was constructed and showed superior performance than model not including LCS. AUC of 6‐month ROC improved from 0.647 (95% CI: 0.584–0.711) to 0.699 (0.638–0.759) in internal validation, and 0.837 (0.734–0.940) to 0.875 (0.784–0.966) in external validation.Conclusions: Liver chemistry score is useful in determining the prognosis of gastric cancer patients with liver metastasis and may be helpful to clinicians in decision‐making.
- Open Access
- 1 January 2022
- Published by XMLink in Journal of Gastric Cancer
- Vol. 22 (2) , 120-134
Determination of Survival of Gastric Cancer Patients With Distant Lymph Node Metastasis Using Prealbumin Level and Prothrombin Time: Contour Plots Based on Random Survival Forest Algorithm on High-Dimensionality Clinical and Laboratory Datasets
Zhang C, et al. J Gastric Cancer. 2022 Apr;22(2):120-134. https://doi.org/10.5230/jgc.2022.22.e12
- 1 January 2022
- Published by XMLink in Journal of Gastric Cancer
- Vol. 22 (2) , 120-134
Open AccessDetermination of Survival of Gastric Cancer Patients With Distant Lymph Node Metastasis Using Prealbumin Level and Prothrombin Time: Contour Plots Based on Random Survival Forest Algorithm on High-Dimensionality Clinical and Laboratory Datasets
Zhang C, et al. J Gastric Cancer. 2022 Apr;22(2):120-134. https://doi.org/10.5230/jgc.2022.22.e12
- Open Access
Prognostic value of different lymph node staging methods for node-positive cardia gastric cancer: a register-based retrospective cohort study
Objective To investigate the prognostic efficacy of lymph node ratio (LNR) and log odds of positive lymph nodes (LODDS) in node-positive cardia gastric adenocarcinoma (CGA). Design A registry-based retrospective cohort study. Setting Patients diagnosed with node-positive CGA in the Surveillance, Epidemiology, and End Results database from 2010 to 2015. Participants A total of 1038 patients were enrolled and randomly assigned (7:3) to the training set (n=723) or validating set (n=315). Primary outcome measure Cancer-specific survival (CSS). Results The baseline characteristics of the training and validation sets were similar. Based on the optimal cut-off values, LNR was classified into low (0.33) groups; LODDS was also classified into low (<−2.09), medium (−2.09~−0.65) and high (>−0.65) groups. CSS was significantly different across LNR and LODDS subgroups. The Harrell concordance index of the N stage was lower than that of the LNR or LODDS. The Akaike information criterion of the N stage was higher than that of the LNR or LODDS. Independent predictors included race, T stage, M stage and LNR (or LODDS), and they were incorporated into nomograms for 1-year, 2-year and 5-year CSS prediction. Calibration plots showed satisfactory results for internal and external validity of the nomogram. Conclusions LNR and LODDS staging methods have better prognostic efficacy than the traditional N staging method in CGA with node metastasis. Moreover, the two values are promising substitutes for N staging in nomogram development when other independent prognostic factors are incorporated.
Open AccessPrognostic value of different lymph node staging methods for node-positive cardia gastric cancer: a register-based retrospective cohort study
Objective To investigate the prognostic efficacy of lymph node ratio (LNR) and log odds of positive lymph nodes (LODDS) in node-positive cardia gastric adenocarcinoma (CGA). Design A registry-based retrospective cohort study. Setting Patients diagnosed with node-positive CGA in the Surveillance, Epidemiology, and End Results database from 2010 to 2015. Participants A total of 1038 patients were enrolled and randomly assigned (7:3) to the training set (n=723) or validating set (n=315). Primary outcome measure Cancer-specific survival (CSS). Results The baseline characteristics of the training and validation sets were similar. Based on the optimal cut-off values, LNR was classified into low (0.33) groups; LODDS was also classified into low (<−2.09), medium (−2.09~−0.65) and high (>−0.65) groups. CSS was significantly different across LNR and LODDS subgroups. The Harrell concordance index of the N stage was lower than that of the LNR or LODDS. The Akaike information criterion of the N stage was higher than that of the LNR or LODDS. Independent predictors included race, T stage, M stage and LNR (or LODDS), and they were incorporated into nomograms for 1-year, 2-year and 5-year CSS prediction. Calibration plots showed satisfactory results for internal and external validity of the nomogram. Conclusions LNR and LODDS staging methods have better prognostic efficacy than the traditional N staging method in CGA with node metastasis. Moreover, the two values are promising substitutes for N staging in nomogram development when other independent prognostic factors are incorporated.
- Open Access
- 20 May 2021
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 9
Childhood Clear Cell Sarcoma of Kidney: Incidence and Survival
This study is to describe current incidence of childhood clear cell sarcoma of kidney (CCSK) and to investigate the present survival of this cancer. Surveillance, Epidemiology, and End Result (SEER) data was used to identify children with CCSK and Wilms tumor (WT) aged 0–19 years in the US. Age-adjusted incidences were estimated over the decades. Age- and sex-specific epidemiology was also presented. Propensity score matching was used to balance features of CCSK and WT cases. Log rank test was used to compare survivals and Cox regression was used to evaluate independent effects of factors. The present age-adjusted incidence of childhood CCSK was 0.205 per million, which remained stable for years and ranked third in all pediatric renal tumors. The incidence rate ratios for boy and age under 4 were 3 and 21, respectively. The current 5-year overall survival (OS) rate for CCSK was 87%, which is not evidently inferior to that for WT (90%); however the outcome of CCSK was significantly poorer if both groups were well-balanced (OS rate was 86 vs. 95%). Early year of diagnosis and distant metastasis were independent survival factors. In conclusion, occurrence of CCSK remains stable over the years, with an age-adjusted incidence of 0.205 per million. Boy and age under 4 are risk factors for tumor development. CCSK currently has a favorable outcome but its nature may be more aggressive than common kidney tumor, which in turn proves efficacy of modern treatment.
- 20 May 2021
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 9
Open AccessChildhood Clear Cell Sarcoma of Kidney: Incidence and Survival
This study is to describe current incidence of childhood clear cell sarcoma of kidney (CCSK) and to investigate the present survival of this cancer. Surveillance, Epidemiology, and End Result (SEER) data was used to identify children with CCSK and Wilms tumor (WT) aged 0–19 years in the US. Age-adjusted incidences were estimated over the decades. Age- and sex-specific epidemiology was also presented. Propensity score matching was used to balance features of CCSK and WT cases. Log rank test was used to compare survivals and Cox regression was used to evaluate independent effects of factors. The present age-adjusted incidence of childhood CCSK was 0.205 per million, which remained stable for years and ranked third in all pediatric renal tumors. The incidence rate ratios for boy and age under 4 were 3 and 21, respectively. The current 5-year overall survival (OS) rate for CCSK was 87%, which is not evidently inferior to that for WT (90%); however the outcome of CCSK was significantly poorer if both groups were well-balanced (OS rate was 86 vs. 95%). Early year of diagnosis and distant metastasis were independent survival factors. In conclusion, occurrence of CCSK remains stable over the years, with an age-adjusted incidence of 0.205 per million. Boy and age under 4 are risk factors for tumor development. CCSK currently has a favorable outcome but its nature may be more aggressive than common kidney tumor, which in turn proves efficacy of modern treatment.
- Open Access
- 1 January 2021
- Published by The Korean Gastric Cancer Association in Journal of Gastric Cancer
- Vol. 21 (3) , 268-278
Performances of Prognostic Models in Stratifying Patients with Advanced Gastric Cancer Receiving First-line Chemotherapy: a Validation Study in a Chinese Cohort
Xu H, et al. J Gastric Cancer. 2021 Sep;21:e26. https://doi.org/10.5230/jgc.2021.21.e26
- 1 January 2021
- Published by The Korean Gastric Cancer Association in Journal of Gastric Cancer
- Vol. 21 (3) , 268-278
Open AccessPerformances of Prognostic Models in Stratifying Patients with Advanced Gastric Cancer Receiving First-line Chemotherapy: a Validation Study in a Chinese Cohort
Xu H, et al. J Gastric Cancer. 2021 Sep;21:e26. https://doi.org/10.5230/jgc.2021.21.e26
- 26 September 2020
- Published by Springer Nature in Biochemical Genetics
- Vol. 59 (1) , 202-218
A Pooled Study of Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in Relation to Risk, Pathology and Prognosis of Childhood Immunoglobulin A Vasculitis Nephritis
The angiotensin-converting enzyme (ACE) insertion/deletion (I/D) gene polymorphism has been inconsistently reported to be a risk factor for Childhood immunoglobulin A vasculitis (IgAV) nephritis. We comprehensively searched electronic databases as of Jan 2020. Nineteen studies with 1104 cases and 1589 controls were included. Sensitivity analyses based on different subgroups were performed. Further analyses were conducted for association of ACE polymorphism with disease severity and prognosis. Significant associations were found between ACE I/D polymorphism and childhood IgAV nephritis, with the strongest association in DD vs. II comparison (OR 1.72, 95% CI 1.21–2.46). Subgroup analyses generally showed significant results. Besides, ACE polymorphism was significantly associated with proteinuria (DD + DI vs. II: OR 2.22, 95% CI 1.14–4.33; DI + II vs. DD: OR 0.49, 95% CI 0.30–0.81) and worse prognosis (the strongest effect in DD + DI vs. II: OR 4.43, 95% CI 1.84–10.71) among children with IgAV nephritis. The ACE polymorphism seemed not to be associated with hematuria, hypertension, and renal pathology. This study suggested significant association of ACE gene polymorphism with the risk of IgAV nephritis in children. D allele in the ACE genotype could be a useful genetic marker to predict proteinuria and worse prognosis for childhood IgAV nephritis.
- 26 September 2020
- Published by Springer Nature in Biochemical Genetics
- Vol. 59 (1) , 202-218
A Pooled Study of Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in Relation to Risk, Pathology and Prognosis of Childhood Immunoglobulin A Vasculitis Nephritis
The angiotensin-converting enzyme (ACE) insertion/deletion (I/D) gene polymorphism has been inconsistently reported to be a risk factor for Childhood immunoglobulin A vasculitis (IgAV) nephritis. We comprehensively searched electronic databases as of Jan 2020. Nineteen studies with 1104 cases and 1589 controls were included. Sensitivity analyses based on different subgroups were performed. Further analyses were conducted for association of ACE polymorphism with disease severity and prognosis. Significant associations were found between ACE I/D polymorphism and childhood IgAV nephritis, with the strongest association in DD vs. II comparison (OR 1.72, 95% CI 1.21–2.46). Subgroup analyses generally showed significant results. Besides, ACE polymorphism was significantly associated with proteinuria (DD + DI vs. II: OR 2.22, 95% CI 1.14–4.33; DI + II vs. DD: OR 0.49, 95% CI 0.30–0.81) and worse prognosis (the strongest effect in DD + DI vs. II: OR 4.43, 95% CI 1.84–10.71) among children with IgAV nephritis. The ACE polymorphism seemed not to be associated with hematuria, hypertension, and renal pathology. This study suggested significant association of ACE gene polymorphism with the risk of IgAV nephritis in children. D allele in the ACE genotype could be a useful genetic marker to predict proteinuria and worse prognosis for childhood IgAV nephritis.